A Paradigm for Gene Regulation: Inflammation, NF-κB and PPAR

  • Wim Vanden Berghe
  • Linda Vermeulen
  • Philippe Delerive
  • Karolien De Bosscher
  • Bart Staels
  • Guy Haegeman
Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 544)

Abstract

Inflammation is a rather general term for a variety of diseases, which appear as different affections depending on the tissue involved. They share a number of common characteristics, among which the expression and secretion of inflammatory cytokines and chemokines.

Keywords

Beach Glucocorticoid Progesterone Acetyl Pyrimidine 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Agalioti, T., Lomvardas, S., Parekh, B., Yie, J., Maniatis, T., and Thanos, D., 2000, Ordered recruitment of chromatin modifying and general transcription factors to the IFN-p promoter. Cell 103: 667–678.CrossRefPubMedGoogle Scholar
  2. Agalioti, T., Chen, G., and Thanos, D., 2002, Deciphering the transcriptional histone acetylation code for a human gene. Cell 111: 381–392.CrossRefPubMedGoogle Scholar
  3. Akimaru, H., Hou, D. X., and Ishii, S., 1997, Drosophila CBP is required for dorsal-dependent twist gene expression. Nat. Genet. 17:211–214.CrossRefPubMedGoogle Scholar
  4. Algarte, M., Kwon, H., Genin, P., and Hiscott, J., 1999, Identification by in vivo genomic footprinting of a transcriptional switch containing NF-kB and Spl that regulates the IkBoi promoter. Mol. Cell. Biol. 19: 6140–6153.PubMedGoogle Scholar
  5. Archer, S. Y., and Hodin, R. A., 1999, Histone acetylation and cancer. Curr. Opin. Genet. Dev. 9: 171–174.CrossRefPubMedGoogle Scholar
  6. Baeuerle, P. A., and Baltimore, D., 1988, IkB: a specific inhibitor of the NF-kB transcription factor. Science 242: 540–546.CrossRefPubMedGoogle Scholar
  7. Berger, S. L., 1999, Gene activation by histone and factor acetyltransferases. Curr. Opin. Cell Biol 11: 336–341.Google Scholar
  8. Blobel, G. A., 2000, CREB-binding protein and p300: molecular integrators of hematopoietic transcription. Blood 95: 745–755.PubMedGoogle Scholar
  9. Boone, E., Vandevoorde, V., De Wilde, G., and Haegeman, G., 1998, Activation of p42/p44 mitogen-activated protein kinases (MAPK) and p38 MAPK by tumor necrosis factor (TNF) is mediated through the death domain of the 55-kDa TNF receptor. FEBSLett. 441:275–280.CrossRefGoogle Scholar
  10. Chen, D., Ma, H., Hong; H., Koh, S. S., Huang, S. M, Schurter, B. T., Aswad, D. W., and Stallcup, M. R., 1999, Regulation of transcription by a protein methyltransferase. Science 284: 2174–2177.CrossRefPubMedGoogle Scholar
  11. Chen, L. F., Mu, Y., and Greene, W. C, 2002, Acetylation of RelA at discrete sites regulates distinct nuclear functions of NF-kB. EMBOJ. 21: 6539–6548.CrossRefGoogle Scholar
  12. Chinetti, G., Griglio, S., Antonucci, M., Torra, I. P., Delerive, P., Majd, Z., Fruchart, J. C, Chapman, J., Najib, J., and Staels, B., 1998, Activation of proliferator-activated receptors a and y induces apoptosis of human monocyte-derived macrophages. J. Biol. Chem. 273: 25573–25580.CrossRefPubMedGoogle Scholar
  13. Deak, M., Clifton, A. D., Lucocq, L. M., and Alessi, D. R., 1998, Mitogen-and stress-activated protein kinase-1 (MSK1) is directly activated by MAPK and SAPK2/p38, and may mediate activation of CREB. EMBOJ. 17:4426–4441.CrossRefGoogle Scholar
  14. Delerive, P., De Bosscher, K., Besnard, S., Vanden Berghe, W., Peters, J. M., Gonzalez, F. J., Fruchart, J. C, Tedgui, A., Haegeman, G., and Staels, B., 1999, Peroxisome proliferator-activated receptor a negatively regulates the vascular inflammatory gene response by negative cross-talk with transcription factors NF-kB and AP-1.J. Biol. Chem. 274: 32048–32054.CrossRefPubMedGoogle Scholar
  15. Delerive, P., Gervois, P., Fruchart, J. C, and Staels, B., 2000, Induction of IkBα expression as a mechanism contributing to the anti-inflammatory activities of peroxisome proliferator-activated receptor-a activators.J. Biol. Chem.275:36703–36707.CrossRefPubMedGoogle Scholar
  16. Delerive, P., De Bosscher, K., Vanden Berghe, W., Fruchart, J. C, Haegeman, G., and Staels, B., 2002, DNA binding-independent induction of IkBα gene transcription by PPARa.Mol. Endocrinol.16:1029–1039.CrossRefPubMedGoogle Scholar
  17. Deng, W. G., Zhu, Y., and Wu, K. K., 2003, Up-regulation of p300 binding and p50 acetylation in tumor necrosis factor-a-induced cyclooxygenase-2 promoter activation.J. Biol. Chem.278:4770–4777.CrossRefPubMedGoogle Scholar
  18. Desvergne, B., and Wahli, W., 1999, Peroxisome proliferator-activated receptors: nuclear control of metabolism.Endocr. Rev.20:649–688.CrossRefPubMedGoogle Scholar
  19. Devchand, P. R., Keller, H., Peters, J. M., Vazquez, M., Gonzalez, F. J., and Wahli, W., 1996, The PPARa-leukotriene B4 pathway to inflammation control.Nature384:39–43.CrossRefPubMedGoogle Scholar
  20. Dixit, V., and Mak, T. W., 2002, NF-kB signaling. Many roads lead to Madrid.Cell111:615–619.CrossRefPubMedGoogle Scholar
  21. El Kharroubi, A., Piras, G., Zensen, R., and Martin, M. A., 1998, Transcriptional activation of the integrated chromatin-associated human immunodeficiency virus type 1 promoter.Mol. Cell. Biol.18:2535–2544.PubMedGoogle Scholar
  22. Gerritsen, M. E., Williams, A. J., Neish, A. S., Moore, S., Shi, Y., and Collins, T., 1997, CREB- binding protein/p300 are transcriptional coactivators of p65.Proc. Natl. Acad. Sci. USA94:2927–2932.CrossRefPubMedGoogle Scholar
  23. Ghosh, S., and Karin, M., 2002, Missing pieces in the NF-kB puzzle.Cell109:S81–96.CrossRefPubMedGoogle Scholar
  24. Giles, R. H., Peters, D. J., and Breuning, M. H., 1998, Conjunction dysfunction: CBP/p300 in human disease.Trends Genet.14:178–183.CrossRefPubMedGoogle Scholar
  25. Gilmore, T. D., 1999, The Rel/NF-KB signal transduction pathway: introduction.Oncogene18:6842–6844.CrossRefPubMedGoogle Scholar
  26. Glass, C. K., and Rosenfeld, M. G., 2000, The coregulator exchange in transcriptional functions of nuclear receptors.Genes Dev.14:121–141.PubMedGoogle Scholar
  27. Gregory, P. D., and Horz, W., 1998, Chromatin and transcription. How transcription factors battle with a repressive chromatin environment.Eur. J. Biochem.251:9–18.CrossRefPubMedGoogle Scholar
  28. Gu, W., and Roeder, R. G., 1997, Activation of p53 sequence-specific DNA binding by acetyl-ation of the p53 C-terminal domain.Cell90:595–606.CrossRefPubMedGoogle Scholar
  29. Hampsey, M., and Reinberg, D., 1999, RNA polymerase II as a control panel for multiple coactivator complexes. Curr. Opin. Genet. Dev.9:132–139.CrossRefPubMedGoogle Scholar
  30. Heyninck, K., De Valck, D., Vanden Berghe, W., Van Criekinge, W., Contreras, R., Fiers, W., Haegeman, G., and Beyaert, R., 1999, The zinc finger protein A20 inhibits TNF-induced NF- KB-dependent gene expression by interfering with an RIP- or TRAF2-mediated transactivation signal and directly binds to a novel NF-KB-inhibiting protein ABIN.J. Cell Biol.145:1471–1482.CrossRefPubMedGoogle Scholar
  31. Holloway, A. F., Rao, S., Chen, X., and Shannon, M. F., 2003, Changes in chromatin accessibility across the GM-CSF promoter upon T cell activation are dependent on nuclear factor kB proteins.J. Exp. Med.197:413–423.CrossRefPubMedGoogle Scholar
  32. Hong, S. H., Wong, C. W., and Privalsky, M. L., 1998, Signaling by tyrosine kinases negatively regulates the interaction between transcription factors and SMRT (silencing mediator of retinoic acid and thyroid hormone receptor) corepressorMol. Endocrinol. 12:1161–1171.CrossRefPubMedGoogle Scholar
  33. Huang, T. T., Kudo, N., Yoshida, M, and Miyamoto, S., 2000, A nuclear export signal in the N- terminal regulatory domain of IkBoc controls cytoplasmic localization of inactive NF-KB/IicBa complexes.Proc. Nad. Acad. Sci. USA97:1014–1019.CrossRefGoogle Scholar
  34. Dceda, K., Steger, D. J., Eberharter, A., and Workman, J. L., 1999, Activation domain-specific and general transcription stimulation by native histone acetyltransferase complexes Mol. Cell. Biol. 19:855–863.Google Scholar
  35. Israel, A., 2000, The IKK complex: an integrator of all signals that activate NF-kB?Trends Cell Biol.10:129–133.CrossRefPubMedGoogle Scholar
  36. Ito, C. Y., Kazantsev, A. G., and Baldwin, A. S., 1994, Three NF-kB sites in the IkB-o, promoter are required for induction of gene expression by TNF a.Nucleic Acids Res.22: 3787–3792.CrossRefPubMedGoogle Scholar
  37. Jacobson, S., and Pillus, L., 1999, Modifying chromatin and concepts of cancer.Curr. Opin. Genet. Dev.9:175–184.CrossRefPubMedGoogle Scholar
  38. Delerive, P., Gervois, P., Fruchart, J. C, and Staels, B., 2000, Induction of IkBα expression as a mechanism contributing to the anti-inflammatory activities of peroxisome proliferator-activated receptor-a activators.J. Biol. Chem.275:36703–36707.CrossRefPubMedGoogle Scholar
  39. Delerive, P., De Bosscher, K., Vanden Berghe, W., Fruchart, J. C, Haegeman, G., and Staels, B., 2002, DNA binding-independent induction of IkBα gene transcription by PPARa.Mol. Endocrinol.16:1029–1039.CrossRefPubMedGoogle Scholar
  40. Deng, W. G., Zhu, Y., and Wu, K. K., 2003, Up-regulation of p300 binding and p50 acetylation in tumor necrosis factor-a-induced cyclooxygenase-2 promoter activation.J. Biol. Chem.278:4770–4777.CrossRefPubMedGoogle Scholar
  41. Desvergne, B., and Wahli, W., 1999, Peroxisome proliferator-activated receptors: nuclear control of metabolism.Endocr. Rev.20:649–688.CrossRefPubMedGoogle Scholar
  42. Devchand, P. R., Keller, H., Peters, J. M., Vazquez, M., Gonzalez, F. J., and Wahli, W., 1996, The PPARa-leukotriene B4 pathway to inflammation control.Nature384:39–43.CrossRefPubMedGoogle Scholar
  43. Dixit, V., and Mak, T. W., 2002, NF-kB signaling. Many roads lead to Madrid.Cell111:615–619.CrossRefPubMedGoogle Scholar
  44. El Kharroubi, A., Piras, G., Zensen, R., and Martin, M. A., 1998, Transcriptional activation of the integrated chromatin-associated human immunodeficiency virus type 1 promoter.Mol. Cell. Biol.18:2535–2544.PubMedGoogle Scholar
  45. Gerritsen, M. E., Williams, A. J., Neish, A. S., Moore, S., Shi, Y., and Collins, T., 1997, CREB- binding protein/p300 are transcriptional coactivators of p65.Proc. Natl. Acad. Sci. USA94:2927–2932.CrossRefPubMedGoogle Scholar
  46. Ghosh, S., and Karin, M., 2002, Missing pieces in the NF-kB puzzle.Cell109:S81–96.CrossRefPubMedGoogle Scholar
  47. Giles, R. H., Peters, D. J., and Breuning, M. H., 1998, Conjunction dysfunction: CBP/p300 in human disease.Trends Genet.14:178–183.CrossRefPubMedGoogle Scholar
  48. Gilmore, T. D., 1999, The Rel/NF-KB signal transduction pathway: introduction.Oncogene18:6842–6844.CrossRefPubMedGoogle Scholar
  49. Glass, C. K., and Rosenfeld, M. G., 2000, The coregulator exchange in transcriptional functions of nuclear receptors.Genes Dev.14:121–141.PubMedGoogle Scholar
  50. Gregory, P. D., and Horz, W., 1998, Chromatin and transcription. How transcription factors battle with a repressive chromatin environment.Eur. J. Biochem.251:9–18.CrossRefPubMedGoogle Scholar
  51. Gu, W., and Roeder, R. G., 1997, Activation of p53 sequence-specific DNA binding by acetyl-ation of the p53 C-terminal domain.Cell90:595–606.CrossRefPubMedGoogle Scholar
  52. Hampsey, M., and Reinberg, D., 1999, RNA polymerase II as a control panel for multiple coactivator complexes. Curr. Opin. Genet. Dev.9:132–139.CrossRefPubMedGoogle Scholar
  53. Heyninck, K., De Valck, D., Vanden Berghe, W., Van Criekinge, W., Contreras, R., Fiers, W., Haegeman, G., and Beyaert, R., 1999, The zinc finger protein A20 inhibits TNF-induced NF- KB-dependent gene expression by interfering with an RIP- or TRAF2-mediated transactivation signal and directly binds to a novel NF-KB-inhibiting protein ABIN.J. Cell Biol.145:1471–1482.CrossRefPubMedGoogle Scholar
  54. Holloway, A. F., Rao, S., Chen, X., and Shannon, M. F., 2003, Changes in chromatin accessibility across the GM-CSF promoter upon T cell activation are dependent on nuclear factor kB proteins.J. Exp. Med.197:413–423.CrossRefPubMedGoogle Scholar
  55. Hong, S. H., Wong, C. W., and Privalsky, M. L., 1998, Signaling by tyrosine kinases negatively regulates the interaction between transcription factors and SMRT (silencing mediator of retinoic acid and thyroid hormone receptor) corepressorMol. Endocrinol. 12:1161–1171.CrossRefPubMedGoogle Scholar
  56. Huang, T. T., Kudo, N., Yoshida, M, and Miyamoto, S., 2000, A nuclear export signal in the N- terminal regulatory domain of IkBoc controls cytoplasmic localization of inactive NF-KB/IicBa complexes.Proc. Nad. Acad. Sci. USA97:1014–1019.CrossRefGoogle Scholar
  57. Dceda, K., Steger, D. J., Eberharter, A., and Workman, J. L., 1999, Activation domain-specific and general transcription stimulation by native histone acetyltransferase complexes Mol. Cell. Biol. 19:855–863.Google Scholar
  58. Israel, A., 2000, The IKK complex: an integrator of all signals that activate NF-kB?Trends Cell Biol.10:129–133.CrossRefPubMedGoogle Scholar
  59. Ito, C. Y., Kazantsev, A. G., and Baldwin, A. S., 1994, Three NF-kB sites in the IkB-o, promoter are required for induction of gene expression by TNF a.Nucleic Acids Res.22: 3787–3792.CrossRefPubMedGoogle Scholar
  60. Jacobson, S., and Pillus, L., 1999, Modifying chromatin and concepts of cancer.Curr. Opin. Genet. Dev.9:175–184.CrossRefPubMedGoogle Scholar
  61. Jin, Y., Wang, Y., Walker, D. L., Dong, H., Conley, C, Johansen, J., and Johansen, K. M., 1999, JIL-1: a novel chromosomal tandem kinase implicated in transcriptional regulation in Drosophila. Mol. Cell 4:129–135.CrossRefPubMedGoogle Scholar
  62. Johnson, C., Van Antwerp, D., and Hope, T. J., 1999, An N-terminal nuclear export signal is required for the nucleocytoplasmic shuttling of IκBα. EMBOJ. 18: 6682–6693.CrossRefGoogle Scholar
  63. Kadonaga, J. T., 1998, Eukaryotic transcription: an interlaced network of transcription factors and chromatin-modifying machines. Cell 92: 307–313.CrossRefPubMedGoogle Scholar
  64. Kieman, R., Bres, V., Ng, R. W., Coudait, M. P., El Messaoudi, S., Sardet, C, Jin, D. Y., Emiliani, S., and Benkirane, M., 2003, Post-activation turn-off of NF-κB-dependent transcription is regulated by acetylation of p65. J. Biol. Chem. 278:2758–2766.CrossRefGoogle Scholar
  65. Ko, L., Cardona, G. R., and Chin, W. W., 2000, Thyroid hormone receptor-binding protein, an LXXLL motif-containing protein, functions as a general coactivator. Proc. Nad. Acad. Sci. USA 97: 6212–6217.CrossRefGoogle Scholar
  66. Kornberg, R. D., and Lorch, Y., 1999, Chromatin-modifying and -remodeling complexes. Curr. Opin. Genet. Dev. 9: 148–151.CrossRefPubMedGoogle Scholar
  67. Korzus, E., Torchia, J., Rose, D. W., Xu, L., Kurokawa, R., Mclnemey, E. M., Mullen, T. M., Glass, C. K., and Rosenfeld, M. G., 1998, Transcription factor-specific requirements for coactivators and their acetyltransferase functions. Science 279: 703–707.CrossRefPubMedGoogle Scholar
  68. Kouzarides, T., 1999, Histone acetylases and deacetylases in cell proliferation. Curr. Opin. Genet. Dev. 9:40–48.CrossRefPubMedGoogle Scholar
  69. Kouzarides, T., 2000, Acetylation: a regulatory modification to rival phosphorylation? EMBO J. 19:1176–1179.CrossRefPubMedGoogle Scholar
  70. Krey, G., Mahfoudi, A., and Wahli, W., 1995, Functional interactions of peroxisome proliferator-activated receptor, retinoid-X receptor, and Spl in the transcriptional regulation of the acyl-coenzyme-A oxidase promoter. Mol. Endocrinol. 9:219–231.CrossRefPubMedGoogle Scholar
  71. Kuo, M. H., and Allis, C. D., 1998, Roles of histone acetyltransferases and deacetylases in gene regulation. BioEssays 20: 615–626.CrossRefPubMedGoogle Scholar
  72. Kurokawa, R., Kalafus, D., Ogliastro, M. H., Kioussi, C, Xu, L., Torchia, J., Rosenfeld, M. G., and Glass, C. K., 1998, Differential use of CREB binding protein-coactivator complexes. Science 279: 700–703.CrossRefPubMedGoogle Scholar
  73. Le Bail, O., Schmidt-Ullrich, R., and Israel, A., 1993, Promoter analysis of the gene encoding the IκB-α/MAD3 inhibitor of κB: positive regulation by members of the rel/NF-κB family. EMBOJ. 12: 5043–5049.Google Scholar
  74. Li, Q., and Verma, I. M, 2002, NF-κB regulation in the immune system. Nat. Rev. Immuhol. 2:725–734.CrossRefGoogle Scholar
  75. Lomvardas, S., and Thanos, D., 2002, Modifying gene expression programs by altering core promoter chromatin architecture. Cell 110:261–271.CrossRefPubMedGoogle Scholar
  76. Malek, S., Chen, Y., Huxford, T., and Ghosh, G., 2001, IκBα, but not IκBα, functions as a classical cytoplasmic inhibitor of NF-κB dimers by masking both NF-κB nuclear localization sequences in resting cells. J. Biol Chem. 276:45225–45235.CrossRefPubMedGoogle Scholar
  77. Marx, N., Sukhova, G. K., Collins, T., Libby, P., and Plutzky, J., 1999, PPARα activators inhibit cytokine-induced vascular cell adhesion molecule-1 expression in human endothelial cells. Circulation 99: 3125–3131.CrossRefPubMedGoogle Scholar
  78. Mercurio, F., and Manning, A. M., 1999, Multiple signals converging on NF-κB. Curr. Opin. Cell Biol 11: 226–232.CrossRefPubMedGoogle Scholar
  79. Merika, M., Williams, A. J., Chen, G., Collins, T., and Thanos, D., 1998, Recruitment of CBP/p300 by the IFN β enhanceosome is required for synergistic activation of transcription. Mol Cell 1:277–287.CrossRefPubMedGoogle Scholar
  80. Merika, M., and Thanos, D., 2001, Enhanceosomes. Curr. Opin. Genet. Dev. 11:205–208.CrossRefPubMedGoogle Scholar
  81. Munshi, N., Merika, M., Yie, J., Senger, K., Chen, G., and Thanos, D., 1998, Acetylation of HMG I(Y) by CBP turns off IFN β expression by disrupting the enhanceosome. Mol Cell 2:457–467.CrossRefPubMedGoogle Scholar
  82. Muraoka, M., Konishi, M., Kikuchi-Yanoshita, R., Tanaka, K., Shitara, N., Chong, J. M., Iwama, T., and Miyaki, M., 1996, p300 gene alterations in colorectal and gastric carcinomas. Oncogene 12:1565–1569.PubMedGoogle Scholar
  83. Owen, G. I., Richer, J. K., Tung, L., Takimoto, G., and Horwitz, K. B., 1998, Progesterone regulates transcription of the p21(WAFl) cyclin-dependent kinase inhibitor gene through Spl and CBP/p300. J. Biol Chem. 273: 10696–10701.CrossRefPubMedGoogle Scholar
  84. Pahl, H. L., 1999, Activators and target genes of Rel/NF-κB transcription factors. Oncogene 18: 6853–6866.CrossRefPubMedGoogle Scholar
  85. Parekh, B. S., and Maniatis, T., 1999, Virus infection leads to localized hyperacetylation of histones H3 and H4 at the IFN-P promoterMol Cell 3: 125–129.CrossRefPubMedGoogle Scholar
  86. Perissi, V., Dasen, J. S., Kurokawa, R., Wang, Z., Korzus, E., Rose, D. W., Glass, C. K., and Rosenfeld, M. G., 1999, Factor-specific modulation of CREB-binding protein acetyltransferase activity.Proc. Natl Acad. Sci. USA 96: 3652–3657.CrossRefPubMedGoogle Scholar
  87. Perkins, N. D., Felzien, L. K., Betts, J. C, Leung, K., Beach, D. H., and Nabel, G. J., 1997, Regulation of NF-kB by cyclin-dependent kinases associated with the p300 coactivator.Science 275: 523–527.CrossRefPubMedGoogle Scholar
  88. Peters, R. T., Liao, S. M., and Maniatis, T., 2000, IKKe is part of a novel PMA-inducible IkB kinase complex.Mol Cell 5: 513–522.CrossRefPubMedGoogle Scholar
  89. Pierrat, B., Correia, J. S., Mary, J. L., Tomas-Zuber, M., and Lesslauer, W., 1998, RSK-B, a novel ribosomal S6 kinase family member, is a CREB kinase under dominant control of p38a mitogen-activated protein kinase (p38aMAPK)J. Biol. Chem 273: 29661–29671.CrossRefPubMedGoogle Scholar
  90. Pollard, K. J., and Peterson, C. L., 1998, Chromatin remodeling: a marriage between two families?BioEssays 20:771–780.CrossRefPubMedGoogle Scholar
  91. Poynter, M. E., and Daynes, R. A., 1998, Peroxisome proliferator-activated receptor a activation modulates cellular redox status, represses nuclear factor-KB signaling, and reduces inflammatory cytokine production in aging.J. Biol. Chem 273:32833–32841.CrossRefPubMedGoogle Scholar
  92. Qi, C, Zhu, Y., Pan, J., Yeldandi, A. V., Rao, M. S., Maeda, N., Subbarao, V., Pulikuri, S., Hashimoto, T., and Reddy, J. K., 1999, Mouse steroid receptor coactivator-1 is not essential for peroxisome proliferator-activated receptor a-regulated gene expression.Proc. Natl. Acad. Sci. USA 96: 1585–1590.CrossRefPubMedGoogle Scholar
  93. Richmond, A., 2002, NF-kB, chemokine gene transcription and tumour growth.Nat. Rev. Immunol 2: 664–674.CrossRefPubMedGoogle Scholar
  94. Ricote, M, Li, A. C, Willson, T. M., Kelly, C. J., and Glass, C. K., 1998, The peroxisome proliferator-activated receptor-y is a negative regulator of macrophage activation.Nature 391:79–82.CrossRefPubMedGoogle Scholar
  95. Rothwarf, D. M., and Karin, M., 1999, The NF-kB activation pathway: a paradigm in information transfer from membrane to nucleusSet STKE 1999: RE1Google Scholar
  96. Saccani, S., Pantano, S., and Natoli, G., 2002, p38 Dependent marking of inflammatory genes for increased NF-kB recruitmentNat. Immunol 3: 69–75.CrossRefPubMedGoogle Scholar
  97. Sakaguchi, K., Herrera, J. E., Saito, S., Miki, T., Bustin, M., Vassilev, A., Anderson, C. W., and Appella, E., 1998, DNA damage activates p53 through a phosphorylation-acetylation cascade.Genes Dev 12:2831–2841.CrossRefPubMedGoogle Scholar
  98. Saville, B., Wormke, M., Wang, F., Nguyen, T., Enmark, E., Kuiper, G., Gustafsson, J. A., and Safe, S., 2000, Ligand-, cell-, and estrogen receptor subtype (a/p)-dependent activation at GC- rich (Spl) promoter elements.J. Biol. Chem 275: 5379–5387.CrossRefPubMedGoogle Scholar
  99. Sheppard, K. A., Rose, D. W., Haque, Z. K., Kurokawa, R., Mclnemey, E., Westin, S., Thanos, D., Rosenfeld, M. G., Glass, C. K., and Collins, T., 1999, Transcriptional activation by NF-kB requires multiple coactivators.Mol. Cell. Biol 19: 6367–6378.PubMedGoogle Scholar
  100. Sheridan, P. L., Mayall, T. P., Verdin, E., and Jones, K. A., 1997, Histone acetyltransferases regulate HIV-1 enhancer activity in vitroGenes Dev 11: 3327–3340.CrossRefPubMedGoogle Scholar
  101. Smale, S. T., and Fisher, A. G., 2002, Chromatin structure and gene regulation in the immune system.Annu. Rev. Immunol 20: 427–462.CrossRefPubMedGoogle Scholar
  102. Staels, B., Dallongeville, J., Auwerx, J., Schoonjans, K., Leitersdorf, E., and Fruchart, J. C, 1998a, Mechanism of action of fibrates on lipid and lipoprotein metabolism.Circulation 98: 2088–2093.CrossRefGoogle Scholar
  103. Staels, B., Koenig, W., Habib, A., Merval, R., Lebret, M., Torra, I. P., Delerive, P., Fadel, A., Chinetti, G., Fruchart, J. C, Najib, J., Maclouf, J., and Tedgui, A., 1998b, Activation of human aortic smooth-muscle cells is inhibited by PPARa but not by PPARy activators.Nature 393: 790–793.CrossRefGoogle Scholar
  104. Strahl, B. D., and Allis, C. D., 2000, The language of covalent histone modifications.Nature 403:41–45.CrossRefPubMedGoogle Scholar
  105. Tarn, W. F., and Sen, R., 2001, IkB family members function by different mechanisms.J. Biol. Chem 276: 7701–7704.CrossRefPubMedGoogle Scholar
  106. Thomson, S., Clayton, A. L., Hazzalin, C. A., Rose, S., Barratt, M. J., and Mahadevan, L. C, 1999, The nucleosomal response associated with immediate-early gene induction is mediated via alternative MAP kinase cascades: MSK1 as a potential histone H3/HMG-14 kinase.EMBO J. 18,4779–4793.CrossRefPubMedGoogle Scholar
  107. Tomas–Zuber, M., Mary, J. L., and Lesslauer, W., 2000, Control sites of ribosomal S6 kinase B and persistent activation through tumor necrosis factor.J. Biol. Chem.275,23549–23558.CrossRefPubMedGoogle Scholar
  108. Torchia, J., Rose, D. W., Inostroza, J., Kamei, Y., Westin, S., Glass, C. K., and Rosenfeld, M. G., 1997, The transcriptional co-activator p/CIP binds CBP and mediates nuclear-receptor function. Nature387,677–684.CrossRefPubMedGoogle Scholar
  109. Torchia, J., Glass, C, and Rosenfeld, M. G., 1998, Co-activators and co-repressors in the integration of transcriptional responses.Curr. Opin. Cell Biol10, 373–383.CrossRefPubMedGoogle Scholar
  110. Tugwood, J. D., Issemann, I., Anderson, R. G., Bundell, K. R., McPheat, W. L., and Green, S., 1992, The mouse peroxisome proliferator activated receptor recognizes a response element in the 5’ flanking sequence of the rat acyl CoA oxidase gene.EMBO J.11,433–439.PubMedGoogle Scholar
  111. Utley, R. T., Ikeda, K., Grant, P. A., Cote, J., Steger, D. J., Eberharter, A., John, S., and Workman, J. L., 1998, Transcriptional activators direct histone acetyltransferase complexes to nucleosomes.Nature394,498–502.CrossRefPubMedGoogle Scholar
  112. Vanden Berghe, W., Plaisance, S., Boone, E., De Bosscher, K., Schmitz, M. L., Fiers, W., and Haegeman, G., 1998, p38 and extracellular signal–regulated kinase mitogen–activated protein kinase pathways are required for nuclear factor–KB p65 transactivation mediated by tumor necrosis factor. J. Biol. Chem.273, 3285–3290CrossRefPubMedGoogle Scholar
  113. Vanden Berghe, W., De Bosscher, K., Boone, E., Plaisance, S., and Haegeman, G., 1999, The nuclear factor-KB engages CBP/p300 and histone acetyltransferase activity for transcriptional activation of the interleukin-6 gene promoter.J. Biol. Chem.274, 32091–32098.CrossRefPubMedGoogle Scholar
  114. Vanden Berghe, W., Vermeulen, L., De Wilde, G., De Bosscher, K., Boone, E., and Haegeman, G., 2000, Signal transduction by tumor necrosis factor and gene regulation of the inflammatory cytokine interleukin-6.Biochem. Pharmacol60,1185–1195.CrossRefPubMedGoogle Scholar
  115. Vanden Berghe, W., De Bosscher, K., Vermeulen, L., De Wilde, G., and Haegeman, G., 2002, Induction and repression of NF-KB-driven inflammatory genes. Ernst Schering Res. Found. Workshop40,233 –278PubMedGoogle Scholar
  116. Vandevoorde, V., Haegeman, G., and Fiers, W., 1997, Induced expression of trimerized intra-cellular domains of the human tumor necrosis factor (TNF) p55 receptor elicits TNF effects.J. Cell Biol137, 1627–1638.CrossRefPubMedGoogle Scholar
  117. Van Lint, C, Emiliani, S., Ott, M., and Verdin, E., 1996, Transcriptional activation and chromatin remodeling of the HIV-1 promoter in response to histone acetylation.EMBOJ.15,1112–1120.Google Scholar
  118. Vermeulen, L., De Wilde, G., Notebaert, S., Vanden Berghe, W., and Haegeman, G., 2002, Regulation of the transcriptional activity of the nuclear factor-KB p65 subunit. Biochem. Pharmacol64, 963–970.CrossRefPubMedGoogle Scholar
  119. Vermeulen, L., De Wilde, G., Van Damme, P., Vanden Berghe, W., and Haegeman, G., 2003, Transcriptional activation of the NF-kB p65 subunit by mitogen-and stress-activated protein kinase-1 (MSK1). EMBO J.22,1313–1324.CrossRefPubMedGoogle Scholar
  120. Wajant, H., Pfizenmaier, K., and Scheurich, P., 2003, Tumor necrosis factor signaling. Cell Death Differ. 10,45–65.CrossRefPubMedGoogle Scholar
  121. Weinmann, A. S., Plevy, S. E., and Smale, S. T., 1999, Rapid and selective remodeling of a positioned nucleosome during the induction of IL-12 p40 transcription.Immunity11, 665–675.CrossRefPubMedGoogle Scholar
  122. Wajant, H., Pfizenmaier, K., and Scheurich, P., 2003, Tumor necrosis factor signaling. Cell Death Differ. 10,45–65.CrossRefPubMedGoogle Scholar
  123. Weinmann, A. S., Mitchell, D. M, Sanjabi, S., Bradley, M. N., Hoffmann, A., Liou, H. C, and Smale, S. T., 2001, Nucleosome remodeling at the IL-12 p40 promoter is a TLR-dependent, Rel-independent event. Nat. Immunol. 2, 51–57.CrossRefPubMedGoogle Scholar
  124. Wesselborg, S., Bauer, M. K., Vogt, M., Schmitz, M. L., and Schulze-Osthoff, K., 1997, Activation of transcription factor NF-kB and p38 mitogen-activated protein kinase is mediated by distinct and separate stress effector pathways.J. Biol Chem.272, 12422–12429.CrossRefPubMedGoogle Scholar
  125. Zhang, S. Q., Kovalenko, A., Cantarella, G., and Wallach, D., 2000, Recruitment of the IKK signalosome to the p55 TNF receptor: RIP and A20 bind to NEMO (IKKy) upon receptor stimulation.Immunity 12: 301–311.CrossRefPubMedGoogle Scholar
  126. Zhong, H., May, M. J., Jimi, E., and Ghosh, S., 2002, The phosphorylation status of nuclear NF- kB determines its association with CBP/p300 or HDAC-1.Mol Cell 9: 625–636.CrossRefPubMedGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2003

Authors and Affiliations

  • Wim Vanden Berghe
    • 1
  • Linda Vermeulen
    • 1
  • Philippe Delerive
    • 2
    • 1
  • Karolien De Bosscher
    • 1
  • Bart Staels
    • 2
  • Guy Haegeman
    • 1
  1. 1.Department of Molecular BiologyUniversity of GentGentBelgium
  2. 2.Institut National de la Santé et de la Recherche Médicale U545, Département d’AthéroscléroseInstitut PasteurLilleFrance

Personalised recommendations